This site is intended for healthcare professionals only
LoginRegister
malaria vaccine price reductionUniversity of Oxford Malaria vaccine gets regulatory clearance for use in Ghana
Robust and variable immunity during COVID-19 in pregnant women observed in studyRobust and variable immunity during COVID-19 in pregnant women observed in study
Flu vaccine did not meet criteria for early success in late-stage trial: ModernaFlu vaccine did not meet criteria for early success in late-stage trial: Moderna
Serum Institute Covovax likely to be available at Rs 225 per dose on CoWIN portalSerum Institute Covovax likely to be available at Rs 225 per dose on CoWIN portal
Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell CarcinomaMerck, Moderna get PRIME scheme designation from EMA for personalized mRNA cancer vaccine, KEYTRUDA...
Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic DermatitisPfizer RSV vaccine 82 percent effective in severe infection in infants: Data
COVID vaccine: SII seeks inclusion of Covovax on CoWIN as heterologous booster dose for adultsCOVID vaccine: SII seeks inclusion of Covovax on CoWIN as heterologous booster dose for adults
Low-risk groups no longer require COVID-19 boosters, recommends WHOLow-risk groups no longer require COVID-19 boosters, recommends WHO
Four COVID vaccine doses superior to three in patients with autoimmune rheumatic diseaseFour COVID vaccine doses superior to three in patients with autoimmune rheumatic disease
USFDA nod to JnJ Tremfya for Crohns diseaseJohnson and Johson to discontinue late-stage study of RSV vaccine
WHO plans to back use of weight-loss drugs for adults globallyCOVID-19 boosters for high-risk adults 6-12 months after last dose: WHO
Covid-19 vaccination not tied to menstrual disturbance, study findsCovid-19 vaccination not tied to menstrual disturbance, study finds
X